Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors

Open access

Abstract

The Wnt/β-catenin pathway, which signals through the Frizzled (Fzd) receptor family and several coreceptors, has long been implicated in cancer. Here we demonstrate a therapeutic approach to targeting the Wnt pathway with a monoclonal antibody, OMP-18R5. This antibody, initially identified by binding to Frizzled 7, interacts with five Fzd receptors through a conserved epitope within the extracellular domain and blocks canonical Wnt signaling induced by multiple Wnt family members. In xenograft studies with minimally passaged human tumors, this antibody inhibits the growth of a range of tumor types, reduces tumor-initiating cell frequency, and exhibits synergistic activity with standard-of-care chemotherapeutic agents.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1120068109

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

See all 624

Metadata

Authors
Gurney, A., Axelrod, F., Bond, C. J., Cain, J., Chartier, C., Donigan, L., Fischer, M., Chaudhari, A., Ji, M., Kapoun, A. M., Lam, A., Lazetic, S., Ma, S., Mitra, S., Park, I.-K., Pickell, K., Sato, A., Satyal, S., Stroud, M., Tran, H., Yen, W.-C., Lewicki, J., & Hoey, T.
Affiliations
  • OncoMed (United States) (US)
  • OncoMed Pharmaceuticals, Redwood City, CA 94063
Venue
Proceedings of the National Academy of Sciences
Published
2012-07-02
Volume
109
Issue
29
Pages
11717-11722
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2069750786
Cited by
614
References
44
Citations by year
2026: 16 · 2025: 33 · 2024: 45 · 2023: 51 · 2022: 53 · 2021: 64 · 2020: 57 · 2019: 50 · 2018: 51 · 2017: 49 · 2016: 45 · 2015: 42 · 2014: 32 · 2013: 20 · 2012: 4
FWCI
12.59
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
MorphoSys
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
Wnt/β-catenin signaling, Frizzled receptors, monoclonal antibodies, tumor growth inhibition, tumorigenicity, cancer stem cells, xenografts, chemosensitization, cancer therapy
MeSH terms
Animals, Antibodies, Monoclonal, Antineoplastic Agents, Cricetulus, Drug Synergism, Genetic Vectors, Cricetinae, Humans, Immunoglobulin Fab Fragments, Immunohistochemistry, Luciferases, Neoplasms, Blotting, Western, Lentivirus, CHO Cells, Peptide Library, Frizzled Receptors, HEK293 Cells, Wnt Signaling Pathway

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. https://app.cochat.ai/papers/10.1073/pnas.1120068109
The paper
Gurney, A., Axelrod, F., Bond, C. J., Cain, J., Chartier, C., Donigan, L., Fischer, M., Chaudhari, A., Ji, M., Kapoun, A. M., Lam, A., Lazetic, S., Ma, S., Mitra, S., Park, I.-K., Pickell, K., Sato, A., Satyal, S., Stroud, M., . . . Hoey, T. (2012). Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1120068109

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.